SA
Sana Biotechnology, Inc.
SANA · NASDAQ
$3.10 +0.32% (+$0.01)
1M -20.72%
Market Cap $862.7M
P/E Ratio -
Div. Yield -
ROE 134.49%
Bulios Fair Price
$2.9
6.5% downside
Trenutna cena
$3.1
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SANA trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
30 /100
Expensive P/B 5.58x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 31.44%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 64.54%
ROE 134.49%
ROA 49.09%
Debt
78 /100
Low Debt/Equity 0.48x
Current ratio 1.38x
Int. coverage N/A
Stability
44 /100
Moderate Beta 2.13x
EPS volatility 12.23%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SANA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Steven D. Harr
Employees
142
Headquarters
Seattle
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report